Literature DB >> 25890716

Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors.

Ai-ting Wang1, De-sheng Liang1, Yu-jie Liu1, Xian-rong Qi2.   

Abstract

There are several obstacles in the process of successful treatment of malignant tumors, including toxicity to normal cells, inefficiency of drug permeation and accumulation into the deep tissue of solid tumor, and multidrug resistance (MDR). In this work, we prepared docetaxel (DTX)-loaded hybrid micelles with DSPE-PEG and TPGS (TPGS/DTX-M), where TPGS serves as an effective P-gp inhibitor for overcoming MDR, and active targeting hybrid micelles (FA@TPGS/DTX-M) with targeting ligand of folate on the hybrid micelles surface offering active targeting to folate receptor-overexpressed tumor cells. A systematic comparative evaluation of these micelles on cellular internalization, sub-cellular distribution, antiproliferation, mitochondrial membrane potential, cell apoptosis and cell cycle, permeation and inhibition on 3-dimensional multicellular tumor spheroids, as well as antitumor efficacy and safety assay in vivo were well performed between sensitive KB tumors and resistant KBv tumors, and among P-gp substrate or not. We found that the roles of folate and TPGS varied due to the sensitivity of tumors and the loaded molecules in the micelles. Folate and folate receptor-mediated endocytosis played a leading role in internalization, permeation and accumulation for sensitive tumors and non-substrates of P-gp. On the contrary, TPGS played the predominant role which dramatically decreased the efflux of drugs both when the tumor is resistant and for P-gp substrate. These findings are very meaningful for guiding the design of carrier delivery system to treat tumors. The antitumor efficacy in xenograft nude mice model and safety assay showed that the TPGS/DTX-M and FA@TPGS/DTX-M significantly exhibited higher antitumor activity against resistant KBv tumors than the marketed formulation and normal micelles owing to the small size (approximately 20 nm), hydrophilic PEGylation, TPGS inhibition of P-gp function, and folate receptor-modified endocytosis, permeation and accumulation in solid tumor, as well as synergistic effects of DTX-induced cell division inhibition, growth restraint and TPGS-triggered mitochondrial apoptosis in tumor cells. In conclusion, folate-modified TPGS hybrid micelles provide a synergistic strategy for effective delivery of DTX into KBv cells and overcoming MDR.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hybrid micelles; Mitochondrial membrane potential; Multidrug resistance; P-gp function; Permeation and accumulation in solid tumor; Synergistic effect

Mesh:

Substances:

Year:  2015        PMID: 25890716     DOI: 10.1016/j.biomaterials.2015.02.077

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

1.  Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.

Authors:  Ya Jin; Zimei Wu; Caibin Li; Weisai Zhou; John P Shaw; Bruce C Baguley; Jianping Liu; Wenli Zhang
Journal:  Pharm Res       Date:  2018-01-04       Impact factor: 4.200

Review 2.  Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models.

Authors:  Sayoni Maitra Roy; Vrinda Garg; Sourav Barman; Chitrita Ghosh; Amit Ranjan Maity; Surya K Ghosh
Journal:  Front Bioeng Biotechnol       Date:  2021-12-01

Review 3.  Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy.

Authors:  Songwei Tan; Chenming Zou; Wei Zhang; Mingxing Yin; Xueqin Gao; Qing Tang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Hyaluronic acid-modified didecyldimethylammonium bromide/ d-a-tocopheryl polyethylene glycol succinate mixed micelles for delivery of baohuoside I against non-small cell lung cancer: in vitro and in vivo evaluation.

Authors:  Hongmei Yan; Jie Song; Xiaobin Jia; Zhenhai Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer.

Authors:  Qiang Huo; Jianhua Zhu; Yimin Niu; Huihui Shi; Yaxiang Gong; Yang Li; Huihui Song; Yang Liu
Journal:  Int J Nanomedicine       Date:  2017-12-04

6.  Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.

Authors:  Yu-Jie Liu; Ying-Cong Ma; Wen-Jie Zhang; Zhen-Zhen Yang; De-Sheng Liang; Zhi-Fu Wu; Xian-Rong Qi
Journal:  Oncotarget       Date:  2017-06-27

Review 7.  Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.

Authors:  Shizhu Chen; Keni Yang; Ruslan G Tuguntaev; Anbu Mozhi; Jinchao Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanomedicine       Date:  2015-12-17       Impact factor: 5.307

8.  d-α-Tocopheryl polyethylene glycol succinate/Solutol HS 15 mixed micelles for the delivery of baohuoside I against non-small-cell lung cancer: optimization and in vitro, in vivo evaluation.

Authors:  Hongmei Yan; Zhenhai Zhang; Xiaobin Jia; Jie Song
Journal:  Int J Nanomedicine       Date:  2016-09-08

9.  Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.

Authors:  Tao Liu; Xidong Wu; Yigang Wang; Tao Zhang; Ting Wu; Fang Liu; Wansong Wang; Gang Jiang; Minqiang Xie
Journal:  Oncotarget       Date:  2016-07-05

10.  Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration.

Authors:  Ling-Hui Dian; Ying-Jie Hu; Jia-Ye Lin; Jing-Ying Zhang; Yan Yan; Yi-Nuo Cui; Zhan-Bo Su; Wan-Liang Lu
Journal:  Int J Nanomedicine       Date:  2018-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.